SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-022699
Filing Date
2016-08-04
Accepted
2016-08-04 16:15:35
Documents
3
Period of Report
2016-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ceru-8k_20160804.htm 8-K 34237
2 EX-99.1 ceru-ex991_22.htm EX-99.1 44510
3 GRAPHIC geo03lhyx0z5000001.jpg GRAPHIC 42424
  Complete submission text file 0001564590-16-022699.txt   138398
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 161807616
SIC: 2834 Pharmaceutical Preparations